Sign inJoin waitlistJoin the waitlist

Joel Neal

Associate Professor of Medicine · Stanford Health Care

Credentials: · · · · ·

History

Hematology and Medical Oncology
Dana-Farber Cancer Institute
2007–2010
Internal Medicine
Beth Israel Deaconess Medical Center
2004–2007
Northwestern University in Chicago
Northwestern University Feinberg School of Medicine
2000–2004

Research

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Nature Medicine · 2014 · 1,763 citations
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
Annals of Oncology · 2019 · 1,133 citations
Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling
Cancer Discovery · 2017 · 877 citations

Heather Wakelee
140 papers
Sukhmani Padda
46 papers
Maximilian Diehn
39 papers
Kavitha Ramchandran
31 papers
Millie Das
31 papers
Jonathan Riess
27 papers · 2 as a fellow
Lecia Sequist
23 papers
Billy Loo
21 papers
JA
Jacqueline Aredo
21 papers · 19 as a resident
Nathaniel Myall
21 papers · 2 as a fellow
Sarah Waliany
18 papers · 18 as a resident
Joseph Shrager
17 papers

Clinical trials

Adjuvant ctDNA-Adapted Treatment With Zipalertinib in Early-Stage Atypical EGFR-Mutant NSCLC
Principal investigator · Not yet recruiting · Phase 2
Stanford University
2026–2028
Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E)
Principal investigator · Suspended · Phase 2
Stanford University
2021–2026
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
Principal investigator · Active not recruiting · Phase 2
National Cancer Institute (NCI)
2020–2026
Pembrolizumab in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer
Principal investigator · Completed · Phase 2
Joel Neal
2016–2024